Prothrombotic factors in stroke;Factores protrombóticos en la enfermedad cerebrovascular isquémica

Neurologia

Volumn 19, Issue 3, 2004, Pages 99-105

  Meseguer, E ^a   Llamas, Pilar ^a   Fernandez De Velasco J ^a   Garcia A ^a   Echevarria A ^a   Ona R ^a   Rabano J ^a   Tomas J F ^a   Garcia De Yebenes J ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

Factor V Leiden; Prothrombin 20210A; Stroke

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; CORRELATION ANALYSIS; DEEP VEIN THROMBOSIS; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; STROKE;

CEREBROVASCULAR ACCIDENT; FACTOR V; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; PROTHROMBIN; RISK FACTORS; VENOUS THROMBOSIS;

EID: 1942423568     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Rothrock JF, Lyden PD, Brody ML, Taft-Alvarez B, Kelly N, Mayer J, et al. An analysis of ischemic stroke in an urban southern California population. The University of California. San Diego: Stroke Data Bank. Arch Intern Med 1993;153:619-24.
2. Catto AJ. Genetic aspects of the hemostatic system in cerebrovascular disease. Neurology 2001;57(Suppl 2):S24-30.
3. Lane DA, Grant PJ. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 2000;95:1517-32.
4. Simioni P, de Ronde H, Prandoni P, Saladini M, Bertina RM, Girolami A. Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds. Stroke 1995;26:885-90.
5. Nowak-Gottl U, Strater R, Dubbers A, Oleszuk-Raschke K, Vielhaber H. Ischaemic stroke in infancy and childhood: role of the Arg506 to Gln mutation in the factor V gene. Blood Coagul Fibrinolysis 1996;7:684-8.
6. Meschia JF, Biller J, Witt T, Greist A, Rhinehart SN. Is hormone replacement a risk factor for ischemic stroke in women with factor V Leiden mutation? Arch Neurol 1998;55:1137-9.
7. Margaglione M, D'Andrea G, Giuliani N, Brancaccio V, De Lucia D, Grandone E, et al. Bilateral thalamic infarction in a patient with factor V Leiden mutation. Mayo Clin Proc 1999;74:795-7.
8. Schutt M, Wiedemann GJ, Seidel G, Neusch C, Vieregge P, Kluter H. Ischemic stroke due to transient thrombosis of the internal carotid artery in a patient with combined antiphospholipid syndrome and factor V Leiden. Am J Med 1999;107:527-8.
9. Rosendaal FR, Siscovick DS, Schwartz SM, Psaty BM, Raghunathan TE, Vos HL. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood 1997;90:1747-50.
10. Price DT, Ridker PM. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective. Ann Intern Med 1997;127:895-903.
11. Catto A, Carter A, Ireland H, Bayston TA, Philippou H, Barrett J, et al. Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke. Arterioscler Thromb Vasc Biol 1995;15:783-5.
12. Ferraresi P, Marchetti G, Legnani C, Cavallari E, Castoldi E, Mascoli F, et al. The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease. Arterioscler Thromb Vasc Biol 1997;17:2418-22.
13. Zunker P, Hohenstein C, Plendl HJ, Zeller JA, Caso V, Georgiadis D, et al. Activated protein C resistance and acute ischaemic stroke: relation to stroke causation and age. J Neurol 2001;248:701-4.
14. Szolnoki Z, Somogyvari F, Kondacs A, Szabo M, Fodor L. Evaluation of the roles of the Leiden V mutation and ACE I/D polymorphism in subtypes of ischaemic stroke. J Neurol 2001;248:756-61.
15. Austin H, Chimowitz MI, Hill HA, Chaturvedi S, Wechsler LR, Wityk RJ, et al. Genetics and stroke in the Young Study Group. Cryptogenic stroke in relation to genetic variation in clotting factors and other genetic polymorphisms among young men and women. Stroke 2002;33:2762-8.
16. Van der Bom JG, Bots ML, Haverkate F, Slagboom PE, Meijer P, de Jong PT, et al. Reduced response to activated protein C is associated with increased risk for cerebrovascular disease. Ann Intern Med 1996;125:265-9.
17. Mohanty S, Saxena R, Behari M. Activated protein C (APC) resistance in young stroke patients. Thromb Haemost 1999;8:465-6.
18. De Stefano V, Chiusolo P, Paciaroni K, Casorelli I, Rossi E, Molinari M, et al. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood 1998;91:3562-5.
19. Szolnoki Z, Somogyvari F, Kondacs A, Szabo M, Fodor L. Evaluation of the interactions of common genetic mutations in stroke subtypes. J Neurol 2002;249:1391-7.
20. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-7.
21. Degen SJ, Davie EW. Nucleotide sequence of the gene for human prothrombin. Biochemistry 1987;26:6165-77.
22. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703.
23. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;346:1133-4.
24. Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998;79:706-8.
25. Adams HP Jr, Bendixen BH, Kappelle U, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. 3rd. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
26. Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci 1993;90:1004-8.
27. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995;332:912-7.
28. Corral J, González-Conejero R, Lozano ML, Rivera J, Heras I, Vicente V. The venous thrombosis risk factor 20210A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease. Br J Haematol 1997;99:304-7.
29. Lalouschek W, Aull S, Serles W, Schnider P, Mannhalter C, Pabinger-Fasching I, et al. C677T MTHFR mutation and factor V Leiden mutation in patients with TIA/minor stroke: a case-control study. Thromb Res 1999;93:61-9.
30. Landi G, Cella E, Martinelli I, Tagliabue L, Mannucci PM, Zerbi D. Arg506Gln factor V mutation and cerebral ischemia in the young. Stroke 1996;27:1697-8.
31. Nabavi DG, Junker R, Wolff E, Ludemann P, Doherty C, Evers S, et al. Prevalence of factor V Leiden mutation in young adults with cerebral ischaemia: a case-control study on 225 patients. J Neurol 1998;245:653-8.
32. Akar N, Yilmaz E, Akar E, Deda G, Sipahi T. Factor V (His 1299 Arg) in young Turkish patients with cerebral infarct. Haemostasis 2000;30:118-22.
33. Kenet G, Sadetzki S, Murad H, Martinowitz U, Rosenberg N, Gitel S, et al. A. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 2000;31:1283-8.
34. Margaglione M, D'Andrea G, Giuliani N, Brancaccio V, De Lucia D, Grandone E, et al. Inherited prothrombotic conditions and pre-mature ischemic stroke: sex differences in the association with Factor V Leiden. Arterioscler Thromb Vase Bio 1999;19:1751-6.
35. Hankey GJ, Eikelboom JW, van Bockxmeer FM, Lofthouse E, Staples N, Baker RI. Inherited thrombophilia in ischemic stroke and its pathogenic subtypes. Stroke 2001;32:1793-9.
36. Karttunen V, Alfthan G, Hiltunen L, Rasi V, Kervinen K, Kesaniemi YA, et al. Risk factors for cryptogenic ischaemic stroke. Eur J Neurol 2002;9:625-32.
37. Pezzini A, del Zotto E, Magoni M, Costa A, Archetti S, Grassi M, et al. Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale. Stroke 2003;34:28-33.
38. De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, et al. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med 1999;341:801-6.